世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Protein Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Insulin, Monoclonal Antibodies, Coagulation Factors {Blood Factors + Tissue Plasminogen}, Vaccines, Growth Factors {Hormones + Cytokine}, and Other Product Types),  By Technology (Irrational Protein Design and Rational Protein Design), By End User (Pharmaceutical and Biotechnology Companies, Academic Institutions, and Contract Research Organizations {CROs}), By Region and Competition,  2020-2030F

Protein Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Insulin, Monoclonal Antibodies, Coagulation Factors {Blood Factors + Tissue Plasminogen}, Vaccines, Growth Factors {Hormones + Cytokine}, and Other Product Types), By Technology (Irrational Protein Design and Rational Protein Design), By End User (Pharmaceutical and Biotechnology Companies, Academic Institutions, and Contract Research Organizations {CROs}), By Region and Competition, 2020-2030F


Market Overview The Global Protein Engineering Market was valued at USD 2.87 billion in 2024 and is projected to reach USD 5.74 billion by 2030, growing at a CAGR of 12.25% during the forecast per... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
TechSci Research
テックサイリサーチ
2025年5月16日 US$4,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
PDF:2営業日程度 189 英語

 

Summary

Market Overview
The Global Protein Engineering Market was valued at USD 2.87 billion in 2024 and is projected to reach USD 5.74 billion by 2030, growing at a CAGR of 12.25% during the forecast period. Protein engineering is a specialized branch of biotechnology that focuses on designing, modifying, and optimizing proteins to enhance or create new functionalities. These proteins serve vital roles in catalysis, signaling, molecular transport, and structural integrity within living systems. Technological advancements in molecular biology now allow researchers to synthesize and alter genes encoding specific proteins, facilitating the development of novel and improved biological molecules. As the demand grows for engineered proteins in applications ranging from therapeutic antibodies to agricultural innovations, the market continues to expand rapidly. Government-backed research funding, growing private investments, and innovation-driven initiatives—such as AI-enabled drug design—are accelerating market development. For instance, Nabla Bio raised USD 11 million in 2021 to build an AI-first platform for next-generation antibody therapeutics, exemplifying the momentum in this sector.
Key Market Drivers
Technological Advancements
Cutting-edge technologies have been instrumental in driving the evolution and expansion of protein engineering applications across sectors such as healthcare, agriculture, and industrial biotechnology. CRISPR-Cas9 has revolutionized gene editing by enabling precise, efficient protein modifications. Directed evolution techniques allow researchers to mimic natural selection in the laboratory to optimize protein functions through iterative mutation and screening. High-throughput screening (HTS) systems have improved the speed and scale of protein testing, enabling rapid identification of proteins with desirable traits. Computational tools, including AI and molecular modeling, now support accurate protein structure predictions and help streamline the design process. Synthetic biology allows for de novo construction of proteins with tailored functionalities, while advances in protein expression systems (yeast, bacterial, and mammalian) have enhanced recombinant protein yields and quality. Collectively, these innovations are facilitating the development of therapeutic proteins, industrial enzymes, and bioengineered agricultural products with unprecedented efficiency.
Key Market Challenges
Complexity of Protein Design
One of the primary challenges in protein engineering is the inherent complexity of protein design. Proteins rely on intricate three-dimensional folding to function correctly, and even minor alterations in amino acid sequences can result in misfolding and loss of activity. Designing proteins that not only fold properly but also exhibit desired properties—such as stability, specificity, and bioactivity—is a highly complex task. Predicting functional outcomes, ensuring correct protein-ligand or protein-protein interactions, and maintaining stability under physiological conditions remain difficult. Additionally, successful protein design demands multidisciplinary expertise in structural biology, computational modeling, bioinformatics, and chemistry, making collaboration essential. These scientific and technical hurdles limit the pace of development and adoption in certain application areas, especially where precision and reproducibility are critical.
Key Market Trends
Expansion of Protein Engineering in Agriculture
Protein engineering is witnessing a growing footprint in agricultural biotechnology. By modifying plant proteins and enzymes, researchers are enhancing crop traits such as pest resistance, disease tolerance, and resilience to environmental stressors like drought and salinity. Engineered crops can also be enriched with essential nutrients, addressing malnutrition through biofortification. These advances reduce the need for chemical inputs like pesticides and fertilizers, promoting more sustainable and eco-friendly farming practices. Protein engineering enables the development of genetically modified organisms (GMOs) with targeted improvements, supporting food security and environmental sustainability. The trend toward nutrient-dense and climate-resilient crops underscores the increasing role of protein engineering in transforming agriculture globally.
Key Market Players
• Agilent Technologies Inc.
• Amgen Inc.
• Bruker Corporation
• Bio-Rad Laboratories Inc.
• Eli Lilly and Company
• Merck KGaA
• Novo Nordisk AS
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
• Waters Corporation
Report Scope:
In this report, the Global Protein Engineering Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Protein Engineering Market, By Product Type:
o Insulin
o Monoclonal Antibodies
o Coagulation Factors (Blood Factors + Tissue Plasminogen)
o Vaccines
o Growth Factors (Hormones + Cytokine)
o Other Product Types
• Protein Engineering Market, By Technology:
o Irrational Protein Design
o Rational Protein Design
• Protein Engineering Market, By End User:
o Pharmaceutical and Biotechnology Companies
o Academic Institutions
o Contract Research Organizations (CROs)
• Protein Engineering Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Asia-Pacific
§ China
§ India
§ South Korea
§ Australia
§ Japan
o Europe
§ Germany
§ France
§ United Kingdom
§ Spain
§ Italy
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Protein Engineering Market.
Available Customizations:
Global Protein Engineering Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る


Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Protein Engineering Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Insulin, Monoclonal Antibodies, Coagulation Factors (Blood Factors + Tissue Plasminogen), Vaccines, Growth Factors (Hormones + Cytokine), and Other Product Types)
5.2.2. By Technology (Irrational Protein Design and Rational Protein Design)
5.2.3. By End User (Pharmaceutical and Biotechnology Companies, Academic Institutions, and Contract Research Organizations (CROs))
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. Asia Pacific Protein Engineering Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Technology
6.2.3. By End User
6.2.4. By Country
6.3. Asia Pacific: Country Analysis
6.3.1. China Protein Engineering Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Technology
6.3.1.2.3. By End User
6.3.2. India Protein Engineering Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Technology
6.3.2.2.3. By End User
6.3.3. Australia Protein Engineering Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Technology
6.3.3.2.3. By End User
6.3.4. Japan Protein Engineering Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Product Type
6.3.4.2.2. By Technology
6.3.4.2.3. By End User
6.3.5. South Korea Protein Engineering Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Product Type
6.3.5.2.2. By Technology
6.3.5.2.3. By End User
7. Europe Protein Engineering Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Technology
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Protein Engineering Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Technology
7.3.1.2.3. By End User
7.3.2. Germany Protein Engineering Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Technology
7.3.2.2.3. By End User
7.3.3. Spain Protein Engineering Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Technology
7.3.3.2.3. By End User
7.3.4. Italy Protein Engineering Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Technology
7.3.4.2.3. By End User
7.3.5. United Kingdom Protein Engineering Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Technology
7.3.5.2.3. By End User
8. North America Protein Engineering Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Technology
8.2.3. By End User
8.2.4. By Country
8.3. North America: Country Analysis
8.3.1. United States Protein Engineering Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Technology
8.3.1.2.3. By End User
8.3.2. Mexico Protein Engineering Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Technology
8.3.2.2.3. By End User
8.3.3. Canada Protein Engineering Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Technology
8.3.3.2.3. By End User
9. South America Protein Engineering Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Technology
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Protein Engineering Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Technology
9.3.1.2.3. By End User
9.3.2. Argentina Protein Engineering Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Technology
9.3.2.2.3. By End User
9.3.3. Colombia Protein Engineering Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Technology
9.3.3.2.3. By End User
10. Middle East and Africa Protein Engineering Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Technology
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Protein Engineering Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Technology
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Protein Engineering Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Technology
10.3.2.2.3. By End User
10.3.3. UAE Protein Engineering Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Technology
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Protein Engineering Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. PESTLE Analysis
16. Competitive Landscape
16.1. Agilent Technologies Inc.
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (In case of listed companies)
16.1.5. Recent Developments
16.1.6. Key Personnel Details

16.1.7. SWOT Analysis
16.2. Amgen Inc.
16.3. Bruker Corporation
16.4. Bio-Rad Laboratories Inc.
16.5. Eli Lilly and Company
16.6. Merck KGaA
16.7. Novo Nordisk AS
16.8. PerkinElmer Inc.
16.9. Thermo Fisher Scientific Inc.
16.10.Waters Corporation
17. Strategic Recommendations
18. About Us & Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

TechSci Research社のヘルスケア分野での最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/05/19 10:28

145.94 円

163.75 円

196.93 円

ページTOPに戻る